INTERQUIM SA

Overview

INTERQUIM SA is an active pharmaceutical ingredient (API) supplier with 24 active FDA Type II Drug Master Files, covering ARIPIPRAZOLE LAUROXIL; ARIPIPRAZOLE MONOHYDRATE; ARIPIPRAZOLE MONOHYDRATE STERILE; CELECOXIB; CICLOPIROX USP; DEXMEDETOMIDINE HYDROCHLORIDE.

API / Drug Master Files

INTERQUIM SA holds 25 active (34 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• EDARAVONEActive2025-02-26
• ARIPIPRAZOLE LAUROXILActive2024-07-30
• FERRIC CARBOXYMALTOSEActive2024-07-17
• ARIPIPRAZOLE MONOHYDRATE STERILEActive2022-08-02
• LIFITEGRASTActive2022-07-18
• LIFITEGRASTActive2022-07-18
• ARIPIPRAZOLE MONOHYDRATEActive2021-03-31
• PYRIMETHAMINEActive2020-08-14
• PALIPERIDONE PALMITATEActive2018-07-26
• FOSFOMYCIN TROMETAMOL (TROMETHAMINE) PH EUR/USPActive2017-04-04
• PALIPERIDONE PALMITATE STERILEActive2016-04-07
• RIVAROXABANActive2015-01-23
• ROFLUMILASTActive2014-07-31
• DEXMEDETOMIDINE HYDROCHLORIDEActive2014-01-06
• CELECOXIBActive2013-02-13

Showing 15 of 34 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to INTERQUIM SA in our records. PharmaTek screens the full directory against live FDA enforcement data.